Who is the CEO of Imunon, Inc.?

The CEO of Imunon, Inc. is Michael Tardugno.

What industry does Imunon, Inc. belong to?

Imunon, Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is Imunon, Inc. headquartered?

Imunon, Inc. is headquartered at 997 Lenox Dr Ste 100, Lawrence Township, NJ, 08648, US.

What is the IPO date of Imunon, Inc.?

Imunon, Inc. went public on October 27, 1993.

How many employees does Imunon, Inc. have?

Imunon, Inc. has approximately 29 full-time employees.

Imunon, Inc.

CLSN•NASDAQ

Healthcare

Biotechnology

$1.95

$-0.01(-0.68%)

Imunon, Inc. (CLSN) Company Profile & Overview

Explore Imunon, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Imunon, Inc. (CLSN) Company Profile & Overview

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

SectorHealthcare

IndustryBiotechnology

CEOMichael Tardugno

Contact Information

https://celsion.com

16098969100

997 Lenox Dr Ste 100, Lawrence Township, NJ, 08648

Company Facts

29 Employees

IPO DateOct 27, 1993

CountryUS

Frequently Asked Questions

;